Malignant Palate Neoplasm — Trials

Malignant Palate Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

4 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1
Recruiting: 1
Ph III recruiting: 1
Growth YoY: —
Industry share: 0%
Top sponsor: NRG Oncology
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1)

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03602079	Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene	completed	Phase 1 / Phase 2	49	Klus Pharma Inc.INDUSTRY	1	Aug 3, 2023	clinicaltrials

Data updated 23 days agoSource updated Aug 3, 2023source: clinicaltrials